Reshape Biotech Analysis: $8M Raised
What is Reshape Biotech?
Reshape Biotech automates lab experiments and data capture, providing AI-driven analysis to enhance scientific research and decision-making.
Employees
40
Founded
2018
Revenue
$3.8-8.3M
Business Model
Subscription-based model with value-based pricing for platform access and services.
Product Features & Capabilities
- Discovery Platform, Imaging Device, High-throughput Imaging Device, automated imaging and analysis, real-time AI analysis, machine learning insights, data standardization, scalable innovation.
Pricing
- Start-up: $2,417 per month, paid annually
- 1 incubated Imaging Device
- Out-of-the-box AI models
- Single lab platform access
- Smooth onboarding to get you started
- Standard: $11,999 per month, paid annually
- 5 incubated Imaging Devices
- Out-of-the-box AI models
- Single
How much Reshape Biotech raised
Seed - $8.1 million
Not specifiedLead Investor: Not specified
Competitors Overview
Reshape Biotech operates in the biotechnology sector, focusing on automating laboratory experiments and utilizing machine learning for data analysis. Its main competitors include:
- Nagi Bioscience: Develops laboratory equipment aimed at reducing animal testing through automated systems for sc
Market Focus
Reshape Biotech primarily focuses on the biotechnology industry, specifically in automating laboratory experiments and enhancing research and development processes through robotics and machine learning technologies.
Investors
- Reshape Biotech raised $20 million in a Series A funding round.
- The investors involved in this funding round have not been explicitly named in the available sources.
See something that needs updating? Suggest edits to this profile.